This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.
Agricola
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, April 2006, p. 2672-2678, Vol. 72, No. 4
0099-2240/06/$08.00+0     doi:10.1128/AEM.72.4.2672-2678.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Both msa Genes in Renibacterium salmoninarum Are Needed for Full Virulence in Bacterial Kidney Disease

Alison M. Coady,1 Anthony L. Murray,2 Diane G. Elliott,2 and Linda D. Rhodes1*

Northwest Fisheries Science Center, 2725 Montlake Boulevard East, Seattle, Washington 98112,1 Western Fisheries Research Center, U.S. Geological Survey, 6505 Northeast 65th Street, Seattle, Washington 981152

Received 10 September 2005/ Accepted 5 February 2006


arrow
ABSTRACT
 
Renibacterium salmoninarum, a gram-positive diplococcobacillus that causes bacterial kidney disease among salmon and trout, has two chromosomal loci encoding the major soluble antigen (msa) gene. Because the MSA protein is widely suspected to be an important virulence factor, we used insertion-duplication mutagenesis to generate disruptions of either the msa1 or msa2 gene. Surprisingly, expression of MSA protein in broth cultures appeared unaffected. However, the virulence of either mutant in juvenile chinook salmon (Oncorhynchus tshawytscha) by intraperitoneal challenge was severely attenuated, suggesting that disruption of the msa1 or msa2 gene affected in vivo expression.


arrow
INTRODUCTION
 
Bacterial kidney disease (BKD) has been reported in most areas of the world where salmonid species are found (4, 11, 13, 20, 27, 28, 35, 37, 42, 46), and it is a principal source of morbidity and mortality among cultured salmon and trout. Acute BKD is characterized by ascites, swollen kidneys, exophthalmia, melanosis, and granulomatous lesions of internal organs such as the kidney, whereas asymptomatic carriers can complete an entire life cycle and successfully spawn (16). The infectious agent of BKD, Renibacterium salmoninarum, can be transmitted both horizontally among cohorts and vertically by intraovum inclusion (2, 14). Current disease controls include broodstock segregation or culling, antibiotic treatment, and vaccination, but these methods have only moderate efficacy in preventing or treating the disease (1, 30, 32).

R. salmoninarum is a gram-positive diplococcobacillus that grows very slowly and has fastidious nutritional requirements (8, 12, 39, 40). R. salmoninarum produces abundant quantities of an extracellular, 57-kDa protein called p57 or major soluble antigen (MSA) (7, 17, 41). MSA is associated with the bacterial surface and is released into surrounding tissues, and it has been associated with leukocyte agglutination (7, 43, 44) and immunomodulation (3, 15, 41, 45). A variant strain of R. salmoninarum displays both reduced MSA expression and lowered mortality upon infection (5, 24, 38), whereas R. salmoninarum isolates possessing an additional copy of the gene encoding MSA are more virulent than isolates lacking the additional copy (32). MSA is encoded by duplicate chromosomal loci (25), and both loci are expressed (33). These observations suggest that MSA is a significant virulence determinant, and we hypothesized that disruption of either chromosomal locus would result in a less virulent strain of R. salmoninarum. The goals of the present study were to generate and characterize R. salmoninarum clones bearing disruptions of either msa1 or msa2, to compare the production of MSA protein in the mutants and the parental R. salmoninarum strain, and to evaluate the virulence of the mutant and parental R. salmoninarum strains for chinook salmon, Oncorhynchus tshawytscha.


arrow
MATERIALS AND METHODS
 
Bacterial strains, media, and culture conditions.
The parental R. salmoninarum strain used for transformation was the ATCC type strain 33209 (American Type Culture Collection, Manassas, VA). Broth and agar plate cultures were grown in modified KDM2 broth and modified KDM2 agar, respectively, as previously described (32). Culture purity was determined by Gram stain, and identity was confirmed by direct fluorescent antibody staining with an anti-R. salmoninarum polyclonal antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD). Kanamycin selection was at 50 µg mL–1 for both liquid and plate cultures. The R. salmoninarum recombinant strains AMC1 and AMC2 are stable transformants of ATCC 33209 with the insertion-duplication mutagenesis (IDM) construct pACP41, described below.

Plasmids.
Plasmid constructions were performed in Escherichia coli Top10 F' {F' [lacIq Tn10 (Tetr)] mcrA{Delta}(mrr-hsdRMS-mcrBC) F80 lacZ{Delta}M15 {Delta}lacX74 recA1 araD139{Delta}(ara-leu)7697 galU galK rpsL (Strr) endA1 nupG}. A 600-bp fragment of the msa open reading frame (ORF) was obtained by PCR amplification with primers p57forwardp4 and CO-4R (Table 1) of pCO2, which contains the entire ORF of msa1 (25). This msa amplicon was ligated into pCRII according to the manufacturer's protocol (Invitrogen), creating pACP4. A 656-bp BamHI-EcoRV fragment was excised from pACP4 and cloned into BamHI-EcoRV-digested pZErO2.1 (Invitrogen), creating pACP41. Orientation of the msa insert in pACP41 was confirmed by restriction analysis and PCR, and sequencing was performed by cycle sequencing with BigDye terminator mix v3.1 and analysis with an ABI 3100 (ABI, Foster City, CA).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Primers used

Transformation of R. salmoninarum.
Transformation of R. salmoninarum was accomplished by electroporation as previously described (33). After electroporation, cells were allowed to recover at 15°C with agitation for 22 to 24 h. Cells were then selected on modified KDM2 plates containing 50 µg ml–1 kanamycin at 15°C. Plates were examined weekly for colony growth.

Chromosomal DNA analysis.
Chromosomal DNA was prepared as previously described (33) and analyzed by standard Southern blotting (36). Probes were random prime labeled with digoxigenin-11-dUTP, and hybridized probes were detected by chemiluminescence according to the manufacturer's instructions (Roche, Indianapolis, IN). The msa probe was synthesized from a 1.06-kb BglII fragment within the msa ORF of pCO2. The pZErO-2.1-specific probe was synthesized from the plasmid without an insert. Analysis of the integration junction was performed by PCR amplification of chromosomal DNA with an msa1-specific primer (CO-22F), an msa2-specific primer (CO-9F), or an msa ORF primer (p57forwardp4, p57reverseB6, or CO-4R) in combination with vector-specific primers (lacZforward, placreverse, M13reverse, M13-40, or Sp6pro) (Table 1). Amplicons were purified (MoBio, Carlsbad, CA) and subjected to cycle sequencing as described above for the plasmid pACP41.

Protein analysis.
Equivalent numbers of R. salmoninarum cells in mid-logarithmic growth (optical density at 525 nm [OD525] between 0.7 and 0.9) were harvested by centrifugation for 15 min at 10,000 x g. Phenylmethylsulfonyl fluoride was added to decanted, filter-sterilized supernatants to a final concentration of 1.4 mM, and equivalent volumes of supernatants were concentrated 50-fold using Centricon-30 filters (Millipore, Billerica, MA). The cell pellet was resuspended in 1.4 mM phenylmethylsulfonyl fluoride and incubated at room temperature with gentle shaking for 1 hour. This suspension was centrifuged for 15 min at 10,000 x g, and the supernatant was removed. This supernatant contained the cell surface-associated protein extract. The remaining cell pellet was resuspended in 0.5% sodium dodecyl sulfate, disrupted in a Branson sonicator at 60°C for 15 min, passaged through a 26-gauge needle 10 times, and centrifuged at 10,000 x g for 10 min. The supernatant from this preparation contained cell-associated protein extract. All preparations (supernatant, cell surface-associated extract, and cell-associated extract) were stored at –20°C until analysis. Samples were heat denatured and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a polyvinylidene difluoride membrane (Millipore, Billerica, MA), and probed with monoclonal antibody 3H1 (44) with standard alkaline phosphatase visualization (19).

Pathogenicity in salmon.
Fish used in the study were a cohort of chinook salmon from the stock at the Soos Creek Hatchery (Washington Department of Fish and Wildlife, Auburn, Wash.). Adult fish were screened at spawning for the presence of R. salmoninarum antigens in kidney tissue by an enzyme-linked immunosorbent assay (ELISA) (30). Eggs from 21 females with no detectable R. salmoninarum antigen were fertilized with milt from 21 males with no detectable R. salmoninarum antigen and selected for the study. Gametes were transported on ice to the Western Fisheries Research Center, Seattle, Wash., for fertilization and hatching and were reared for about 6 months after hatching. Fish were maintained in sand-filtered, UV-treated Lake Washington water at 12°C throughout the study and were fed ad libitum with a pelleted, semimoist commercial salmon diet (Bio-Oregon, Warrenton, OR).

R. salmoninarum strains used for the challenges included the parental ATCC type strain 33209, a clone with an msa1 disruption (AMC1), and a clone with an msa2 disruption (AMC2). Challenge cultures were grown in modified KDM2 broth as previously described (32), except that the culture medium for AMC1 and AMC2 contained kanamycin at 50 µg ml–1. The cultures were grown for 5 to 7 days at 15°C with stirring to an OD525 of ≥0.6 and then were harvested by centrifugation at 5,000 x g for 20 min and resuspended in 0.01 M phosphate-buffered saline, pH 7.4 (PBS), supplemented with 0.1% peptone (PBS-peptone). Bacteria were enumerated by the membrane filtration fluorescent antibody technique (10) and diluted to the appropriate concentration in PBS-peptone. Bacterial viability was confirmed by culture plate counts. Because differences in growth rates among the R. salmoninarum strains created difficulties in achieving synchronous bacterial growth of all strains on a given date, separate injection and immersion challenges were conducted comparing AMC1 to 33209 and AMC2 to 33209.

For each injection challenge, fish (mean weight, 3.6 g) were anesthetized with tricaine methanesulfonate (MS-222; Argent Chemical Laboratories, Redmond, WA) and injected intraperitoneally with 50 µl of PBS-peptone (vehicle control) or an equal volume of one of the R. salmoninarum isolates at 1 x 106 bacteria fish–1. One hundred fish were included in each injection group. Fish were held in 122-liter circular, flowthrough tanks at 12°C and monitored daily for 115 days. Kidneys from mortalities were tested for the presence of R. salmoninarum by a direct fluorescent antibody test (30) and by plate culture to confirm cause of death.

For each treatment group in the immersion challenge, 100 fish (4.6 g mean weight) were placed in 8 liters of water containing 40 ml of one of the R. salmoninarum strains or an equal volume of PBS-peptone (vehicle control). Each treatment was performed in duplicate at a final challenge concentration of 1 x 107 bacteria ml–1 in a static system for 24 h. The challenge water temperature was maintained at 12°C, and oxygen was continuously supplied to each bucket during challenge. At the end of the challenge, fish were placed in 122-liter circular, flowthrough tanks at 12°C and monitored daily for 150 days. Kidneys from mortalities were tested for the presence of R. salmoninarum by direct fluorescent antibody test and plate culture. Kidneys from fish surviving at the end of the postchallenge monitoring period were randomly subsampled (30 per tank, 60 per treatment) and analyzed individually for R. salmoninarum antigen levels by ELISA (30). The genotypes of all challenge strains and the bacteria recovered from mortalities were confirmed by PCR and Southern blot hybridization.

Survival curves were estimated by the Kaplan-Meier algorithm and compared by the log rank test. For comparison of R. salmoninarum antigen levels in fish testing positive by the ELISA within a given challenge group, a log transformation was first applied to ELISA absorbance values to achieve common variances of means among various data groups (11). Student's t test was then used to compare R. salmoninarum antigen levels between the two groups of fish exposed to R. salmoninarum in a challenge.


arrow
RESULTS
 
Transformation of R. salmoninarum.
Because previous work demonstrated R. salmoninarum could be stably transformed by single-crossover homologous recombination at a very low frequency (33), we chose to use an IDM approach. Sequence analysis of the msa fragment in the IDM construct pACP41 identified a single base insertion positioned 90 bp from the upstream primer site, creating an in-frame stop codon with the remainder of the msa ORF. Because both copies of msa have identical ORFs, homologous recombination could occur with either msa1 or msa2. Parallel aliquots of type strain ATCC 33209 were electroporated with no DNA, a plasmid lacking an insert (pZErO2.1), a plasmid previously used in homologous recombination experiments with R. salmoninarum (pLDR109), or pACP41. Ten weeks after growth under selection, colonies were visible for the electroporation with pLDR109 or pACP41, but not for the electroporation with pZErO2.1 or with no DNA. The cells from these colonies were gram-positive diplococcobacilli that were labeled with anti-R. salmoninarum polyclonal antibody. The integration frequency of pACP41 was 108 CFU µg–1 DNA.

Genotype of transformed R. salmoninarum.
The candidate recombinant clones were screened by PCR with either an msa1-specific or msa2-specific primer with a vector primer for evidence of homologous recombination. Amplification by msa1-specific PCR generated a 1.35-kb product from some clones, whereas amplification by msa2-specific PCR generated a 1.04-kb amplicon from other clones. Amplification with the primer pairs was mutually exclusive, and neither pair generated a product from DNA from the parental 33209 strain (Fig. 1). The observed 1.35-kb and 1.04-kb amplicons were consistent with predicted patterns resulting from homologous recombination at the msa1 or msa2 locus, respectively, and clones with potential integrations were further analyzed by Southern blot hybridization and sequence analysis.


Figure 1
View larger version (23K):
[in this window]
[in a new window]
 
FIG. 1. PCR amplifications specific for the msa1 (left image) or msa2 (right image) locus. The upstream primer for each reaction was specific for one msa locus, and the downstream primer was specific for vector pZeRO2.1. Expected product sizes were 1.35 kb for msa1 integration and 1.05 kb for msa2 integration. Templates used were the parental ATCC type strain 33029 (lane 1), clones with msa2 integrations (lanes 2 and 3), and clones with msa1 integrations (lanes 4, 5, and 6). The molecular mass marker (lane 7) is a 1-kb ladder (New England BioLabs), and marker sizes (in kilobases) are shown to the right of each image.

Southern blot hybridization with an msa ORF probe revealed two patterns, and both patterns differed from that for the parental 33209 strain. For a BamHI digestion, one pattern lacked the 5.1-kb band specific for msa1 (32) and displayed novel 2.4-kb and 6.4-kb bands, while the 7.0-kb band that is specific for msa2 was unaltered (Fig. 2). This pattern is consistent with integration of pACP41 into the msa1 locus (Fig. 3A). The second pattern lacked the msa2-specific 7.0-kb BamHI band and displayed novel 4.0-kb and 6.7-kb bands, while the msa1-specific 5.1-kb band was unaltered (Fig. 2). This pattern is consistent with integration of pACP41 into the msa2 locus (Fig. 3B). Hybridization with chromosomal DNA digested with HindIII or XhoI also yielded dual pattern results (Fig. 2), which corroborated the predictions of integration into msa1 or msa2 (Fig. 3). Hybridization with a probe generated from an empty pZeRO2.1 vector confirmed the presence of vector sequences of the expected restriction fragment size (data not shown).


Figure 2
View larger version (95K):
[in this window]
[in a new window]
 
FIG. 2. Southern blot of 1 µg of chromosomal DNA from the parental strain and selected integration clones hybridized with an msa ORF probe. Chromosomal DNAs, digested with the indicated enzyme, were from the parental ATCC type strain 33209 (lanes 1), one clone bearing msa1 integrations (lanes 2), and one clone bearing msa2 integrations (lanes 3). Lane s1 contains molecular mass marker II (Boehringer Mannheim), and relative masses are labeled to the left. Lane s2 contains molecular mass marker VII (Boehringer Mannheim), and relative masses are labeled to the right. Sizes are in kilobases. Blot images were captured with an ImageStation 440CF using 1D Image Analysis software, v. 3.5.3 (Kodak).


Figure 3
View larger version (11K):
[in this window]
[in a new window]
 
FIG. 3. Schematic representation of the organization of the chromosomal integration sites at the msa1 locus (A) or msa2 locus (B). Chromosomal sequences are represented by thick lines, and plasmid sequences are represented by thin lines. The plasmid gene conferring resistance to kanamycin is labeled "kan." The msa ORF fragment in pACP41 is a shaded box. The approximate position of an in-frame stop codon is indicated by a short, vertical arrow. The position of the msa ORF probe used in Southern hybridizations is shown by a diagonally hatched box beneath the msa1 figure. Restriction sites are indicated beneath each figure as follows: B, BamHI; H, HindIII; X, XhoI.

The 5' and 3' integration sites of selected clones were amplified with combinations of vector primers and primers specific to msa1, msa2, or the msa ORF, and the amplicons were sequenced. The integrations were precise to the nucleotide (data not shown). Furthermore, the point mutation introduced in pACP41 permitted determination of the position of the msa fragment in pACP41 within the chromosomal integration. For each msa integration, the cloned msa fragment was located 3' to the plasmid sequences and the homologous chromosomal sequences (Fig. 3).

Expression of MSA in transformed R. salmoninarum.
The IDM construct pACP41 was designed to disrupt expression from either msa gene upon integration. Because both msa1 and msa2 are transcriptionally active, a decrease in MSA expression was expected if one locus was inactivated. MSA protein expressed in broth cultures can be fractioned into three compartments: MSA released from the cell (supernatant), MSA weakly associated with the cell surface (cell surface associated), and MSA strongly associated with the cell (cell associated). MSA expression of the parental ATCC type strain 33209 was compared with expression from clones with disruption of msa1 (AMC1) or msa2 (AMC2). Equivalent numbers of cells were harvested from late-logarithmic-phase broth cultures (OD525 of 0.9 to 1.2), and the three protein fractions were isolated and analyzed by Western blot analysis with a monoclonal antibody against MSA. Surprisingly, the levels of MSA from all three fractions were not significantly different among the parental strain, AMC1, and AMC2 (Fig. 4).


Figure 4
View larger version (61K):
[in this window]
[in a new window]
 
FIG. 4. Western blot of cell-associated extract (CA), cell surface-associated extract (CSE), and supernatant (SUP) from broth cultures of the parental strain (lanes 1), a clone bearing an msa1 disruption (lanes 2), and a clone bearing an msa2 disruption (lanes 3). Cell-equivalent amounts of protein for each strain were analyzed, and MSA protein was identified with monoclonal antibody. Lane m contains molecular mass standards, and indicated sizes are in kilodaltons. The blot image was captured with an ImageStation 440CF using 1D Image Analysis software, v. 3.5.3 (Kodak).

Virulence of integration clones in chinook salmon.
In separate injection challenges, we compared the parental type strain, 33209, to either AMC1 (challenge 2) or AMC2 (challenge 1), and both challenges were terminated at 115 days postinjection. The parental type strain caused significantly greater mortality throughout the study period (P < 0.001; log rank test) than either of the two mutants (Fig. 5a and b). At the conclusion of the challenges, survival among fish exposed to AMC1 was 74%, and among fish exposed to AMC2 it was 85%, whereas survival among fish exposed to the parental type strain 33209 was 21% and 16%, respectively. In comparison, survival in the PBS-peptone-injected control groups exceeded 98%. Median survival among fish exposed to the parental wild-type strain 33209 was 65 days in each challenge.


Figure 5
View larger version (16K):
[in this window]
[in a new window]
 
FIG. 5. Cumulative percent survival in groups of chinook salmon challenged by intraperitoneal injection with PBS-peptone (vehicle control) or one of the R. salmoninarum strains. Fish were held in 12°C water and monitored daily for 115 days after challenge; data markers are shown at 10-day intervals. (a) Survival of fish injected with the parental type strain ATCC 33209 or with a clone bearing an msa2 disruption (AMC2). (b) Survival of fish injected with the parental type strain 33209 or with a clone bearing an msa1 disruption (AMC1).

At the conclusion of the immersion challenges (150 days after exposure), survival was 94% to 95% in groups of fish exposed to any of the R. salmoninarum isolates, with no significant difference in survival among the R. salmoninarum-challenged groups (P > 0.05). Survival in the PBS-peptone control groups was 99%. A subsample of surviving fish in each treatment group was analyzed for R. salmoninarum antigens in the kidney tissue by ELISA, and ≥98% of fish exposed to either AMC1 or AMC2 or to the parental type strain 33209 tested positive for R. salmoninarum antigens (data not shown). However, Student's t comparison of transformed ELISA ODs from tissues of infected fish showed that bacterial antigen levels in fish exposed to either AMC1 or AMC2 were significantly lower (P < 0.0001 and P = 0.012, respectively) than levels in fish exposed to the parental wild-type strain.

Isolates were cultured from challenge mortalities, and for challenges with the integration clones isolates were recovered both with and without kanamycin selection. The msa genotype of isolates recovered from mortalities was characterized by PCR and by Southern blot analysis. In all cases, the msa genotype of the recovered isolates matched that of the challenge strain (data not shown).


arrow
DISCUSSION
 
Although the MSA protein has been previously implicated as an important virulence factor in BKD, this study provides the first empirical evidence that each msa gene is necessary for full pathogenicity by R. salmoninarum. The MSA protein has been implicated as a significant factor in pathogenicity of R. salmoninarum, in part because of its abundance on the bacterial surface and its high immunogenicity. MSA mediates agglutination of eukaryotic cells (salmon leukocytes, trout spermatozoa, and rabbit erythrocytes) and bacterial autoagglutination (5, 7, 15, 43, 44), and greatly reduced levels of MSA are associated with loss of agglutination and lowered virulence (5, 24, 38, 45). The role of MSA in BKD pathogenicity is unknown, although its putative activities include immunosuppression (3, 15, 41), proteolytic activity (34), and modulation of the macrophage respiratory burst (9).

The injection challenge experiments were monitored far beyond the median survival of the parental wild-type strain and demonstrated that each mutant had significantly attenuated virulence. Isolates recovered from mortalities retained the msa genotype of the respective challenge strain, indicating that the integrations are stable through disease progression and subsequent culture without selection. Because chromosomal regions known to be benign for R. salmoninarum function have not yet been identified, our design did not include plasmid integrations into other sites for comparative virulence testing. The growth of both msa mutants in broth culture is indistinguishable from the parental strain (data not shown), suggesting that the plasmid sequences are not inhibitory. However, the effects of the integrated plasmid sequences during infection and disease are unknown and may contribute to the attenuated phenotype.

In contrast to the injection challenges, the immersion challenges resulted in low mortality during the 150-day monitoring period, even for the parental wild-type strain. This is not surprising, considering the chronic nature of BKD; the mean time to death may exceed 200 days for fish challenged by immersion with virulent R. salmoninarum at an average water temperature of 12.6°C (23). Significantly lower levels of bacterial antigens detected in kidneys from surviving fish challenged with AMC1 or AMC2 in comparison to 33209 could be indicative of a reduced bacterial ability to establish infection, effective clearance by the host, or slower proliferation by the bacterium. The finding that ≥89% of surviving fish challenged with any of the R. salmoninarum strains showed medium to high R. salmoninarum antigen levels (OD405 ≥ 0.200) (11, 30) at the termination of the monitoring period suggested that all strains of the bacterium proliferated to some extent in the majority of fish after immersion exposure. Nevertheless, because ELISA cannot distinguish between antigens of live and dead R. salmoninarum organisms and antigens from the bacterium can persist for at least 110 days in the absence of live bacteria (31), the ELISA analysis could not determine whether reduced antigen levels in fish challenged with AMC1 or AMC2 resulted from slower proliferation of the mutant strains, from more effective clearance of these strains by the host after initial infection, or from a combination of factors. Further investigation of the ability of AMC1 or AMC2 to establish infections through horizontal transmission may require more rapidly efficacious exposure conditions, such as cohabitation with severely infected fish (21, 23), and the use of a method such as culture for enumeration of viable R. salmoninarum in fish.

Disruption of the msa locus was accomplished by insertion-duplication mutagenesis with a plasmid containing 600 bp of cloned msa sequence and a selectable kanamycin marker. There is physical evidence that homologous recombination and integration of this plasmid disrupted the targeted gene loci. The integrations into the chromosomal loci were precise, resulting in a drastically truncated msa ORF (694 bp out of 1,677 bp) adjacent to the endogenous promoter and a partial msa ORF lacking both the endogenous promoter and the first 94 bp positioned 3' to the integrated plasmid sequences (Fig. 2). Although it is possible that a promoter(s) within the plasmid sequence could have initiated transcription into the downstream, partial msa ORF, the in-frame stop codon introduced by PCR within the msa fragment in the IDM construct would halt translation near the beginning of the ORF (Fig. 2). Furthermore, evidence of truncated MSA products unique to either IDM mutant was not observed in Western blot analysis of protein fractions.

Our previous attempts to employ transposon mutagenesis (e.g., Tn10 and Tn5) for gene disruption were unsuccessful, suggesting that common transposases may not be active in R. salmoninarum. We chose to exploit IDM, a method successfully used for over 20 years (22, 26), to disrupt bacterial gene expression because we had previously observed homologous recombination in R. salmoninarum (33). Our IDM plasmid was not specifically designed to permit transcription through the cloned inserts to ensure nonpolar mutations (18). However, there is a 97-bp hairpin structure starting 6 bp upstream of the msa ORF stop codon in each chromosomal msa locus that presents a strong transcriptional termination motif (6), suggesting that the IDM was unlikely to have a polar effect in the direction of msa transcription at either locus. There is no strong termination motif in the 5'-flanking regions of either locus, and it is formally possible that the observed attenuated phenotypes are due to polar effects on genes positioned 5' to both msa genes. To date, no plasmids have been identified in R. salmoninarum, eliminating the opportunity to test for polar effects through complementation.

The absence of an effect upon in vitro expression of MSA by the disruption of either locus could be a result of posttranscriptional, translational, or posttranslational regulation, because previous analysis showed that both loci are transcribed in vitro (33). Both msa loci have identical sequences extending from 40 bp upstream of the ORF through 225 bp downstream of the ORF, and our efforts to identify unique transcribed sequences for each msa locus have been unsuccessful (unpublished observations), suggesting that transcription initiates within common sequences. The requirement for both genes for full virulence may be due to differential regulation of gene expression or the protein level in vivo.

In summary, we have used IDM to disrupt expression from each chromosomal locus of msa and provided evidence that each locus is required for full virulence of R. salmoninarum. If MSA interferes with an effective host response to infection, ablation of MSA is predicted to result in a highly attenuated strain that may be a vaccine candidate against BKD. Therefore, targeting a double mutant at both msa loci is a priority.


arrow
ACKNOWLEDGMENTS
 
We thank LynnMarie Applegate, Connie McKibben, and Rebecca Deinhard for expert technical assistance with this research. Monoclonal antibody 3H1 was a gift from Gregory Wiens, James Winton, and Ronald Pascho. Three anonymous journal reviewers provided insights and suggestions that substantially improved the manuscript.

A.M.C. was supported by CSREES grant 00-35204-9225 from the U.S. Department of Agriculture. The National Marine Fisheries Service (National Oceanic and Atmospheric Administration, U.S. Department of Commerce) and U.S. Geological Survey (U.S. Department of the Interior) provided substantial support.

Mention of trade names or commercial products in this paper is solely for the purpose of providing specific information and does not imply recommendation or endorsement.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Northwest Fisheries Science Center, 2725 Montlake Blvd. East, Seattle, WA 98112. Phone: (206) 860-3279. Fax: (206) 860-3467. E-mail: linda.rhodes{at}noaa.gov. Back


arrow
REFERENCES
 
    1
  1. Alcorn, S., A. L. Murray, R. J. Pascho, and J. Varney. 2005. A cohabitation challenge to compare the efficacies of vaccines for bacterial kidney disease (BKD) in chinook salmon Oncorhynchus tshawytscha. Dis. Aquat. Organ. 63:151-160.[Medline]
  2. 2
  3. Balfry, S. K., L. J. Albright, and T. P. T. Evelyn. 1996. Horizontal transfer of Renibacterium salmoninarum among farmed salmonids via the fecal-oral route. Dis. Aquat. Organ. 25:1-2.
  4. 3
  5. Brown, L. L., G. K. Iwama, and T. P. T. Evelyn. 1996. The effect of early exposure of coho salmon (Oncorhynchus kisutch) eggs to the p57 protein of Renibacterium salmoninarum on the development of immunity to the pathogen. Fish Shellfish Immunol. 6:149-165.
  6. 4
  7. Bruno, D. W. 2004. Prevalence and diagnosis of bacterial kidney disease (BKD) in Scotland between 1990 and 2002. Dis. Aquat. Organ. 59:125-130.[Medline]
  8. 5
  9. Bruno, D. W. 1988. The relationship between auto-agglutination, cell surface hydrophobicity and virulence of the fish pathogen Renibacterium salmoninarum. FEMS Microbiol. Lett. 51:135-140.[CrossRef]
  10. 6
  11. Chien, M. S., T. L. Gilbert, C. Huang, M. L. Landolt, P. J. O'Hara, and J. R. Winton. 1992. Molecular cloning and sequence analysis of the gene coding for the 57-kDa major soluble antigen of the salmonid fish pathogen Renibacterium salmoninarum. FEMS Microbiol. Lett. 75:259-265.[Medline]
  12. 7
  13. Daly, J. G., and R. M. Stevenson. 1990. Characterization of the Renibacterium salmoninarum haemagglutinin. J. Gen. Microbiol. 136:949-953.[Abstract/Free Full Text]
  14. 8
  15. Daly, J. G., and R. M. W. Stevenson. 1993. Nutrient requirements of Renibacterium salmoninarum on agar and in broth media. Appl. Environ. Microbiol. 59:2178-2183.[Abstract/Free Full Text]
  16. 9
  17. Densmore, C. L., S. A. Smith, and S. D. Holladay. 1998. In vitro effects of the extracellular protein of Renibacterium salmoninarum on phagocyte function in brook trout (Salvelinus fontinalis). Vet. Immunol. Immunopathol. 62:349-357.[CrossRef][Medline]
  18. 10
  19. Elliott, D. G., and C. L. McKibben. 1997. Comparison of two fluorescent antibody techniques (FATs) for detection and quantification of Renibacterium salmoninarum in coelomic fluid of spawning chinook salmon Oncorhynchus tshawytscha. Dis. Aquat. Organ. 30:37-43.[CrossRef]
  20. 11
  21. Elliott, D. G., R. J. Pascho, L. M. Jackson, G. M. Matthews, and J. R. Harmon. 1997. Renibacterium salmoninarum in spring-summer chinook salmon smolts at dams on the Columbia and Snake Rivers. J. Aquat. Anim. Health 9:114-126.
  22. 12
  23. Evelyn, T. P. T. 1977. An improved growth medium for the kidney disease bacterium and some notes on using the medium. Bull. Off. Int. Epizoot. 87:511-513.
  24. 13
  25. Evelyn, T. P. T., G. E. Hoskins, and G. R. Bell. 1973. First record of bacterial kidney disease in an apparently wild salmonid in British Columbia. J. Fish. Res. Board Can. 30:1578-1580.
  26. 14
  27. Evelyn, T. P. T., J. E. Ketcheson, and L. Prosperi-Porta. 1984. Further evidence for the presence of Renibacterium salmoninarum in salmonid eggs and for the failure of povidine-iodine to reduce the intra-ovum infection in water-hardened eggs. J. Fish Dis. 7:173-182.
  28. 15
  29. Fredriksen, A., C. Endresen, and H. I. Wergeland. 1997. Immunosuppressive effect of a low molecular weight surface protein from Renibacterium salmoninarum on lymphocytes from Atlantic salmon (Salmo salar L). Fish Shellfish Immunol. 7:273-282.
  30. 16
  31. Fryer, J. L., and C. N. Lannan. 1993. The history and current status of Renibacterium salmoninarum, the causative agent of bacterial kidney disease in Pacific salmon. Fish Res. 17:15-33.
  32. 17
  33. Getchell, R. G., J. S. Rohovec, and J. L. Fryer. 1985. Comparison of Renibacterium salmoninarum isolates by antigenic analysis. Fish Pathol. 20:149-159.
  34. 18
  35. Hamilton, H. L., K. J. Schwartz, and J. P. Dillard. 2001. Insertion-duplication mutagenesis of Neisseria: use in characterization of DNA transfer genes in the gonococcal genetic island. J. Bacteriol. 183:4718-4726.[Abstract/Free Full Text]
  36. 19
  37. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  38. 20
  39. Jonsdottir, H., H. J. Malmquist, S. S. Snorrason, G. Gudbergsson, and S. Gudmundsdottir. 1998. Epidemiology of Renibacterium salmoninarum in wild Arctic charr and brown trout in Iceland. J. Fish Biol. 53:322-339.[CrossRef]
  40. 21
  41. McKibben, C. L., and R. J. Pascho. 1999. Shedding of Renibacterium salmoninarum by infected chinook salmon Oncorhynchus tschawytscha. Dis. Aquat. Organ. 38:75-79.[Medline]
  42. 22
  43. Morrison, D. A., M. C. Trombe, M. K. Hayden, G. A. Waszak, and J. D. Chen. 1984. Isolation of transformation-deficient Streptococcus pneumoniae mutants defective in control of competence, using insertion-duplication mutagenesis with the erythromycin resistance determinant of pAM beta 1. J. Bacteriol. 159:870-876.[Abstract/Free Full Text]
  44. 23
  45. Murray, C. B., T. P. T. Evelyn, T. D. Beacham, L. W. Barner, J. E. Ketcheson, and L. Prosperi-Porta. 1992. Experimental induction of bacterial kidney disease in chinook salmon by immersion and cohabitation challenges. Dis. Aquat. Organ. 12:91-96.
  46. 24
  47. O'Farrell, C. L., D. G. Elliott, and M. L. Landolt. 2000. Mortality and kidney histopathology of chinook salmon Oncorhynchus tshawytscha exposed to virulent and attenuated Renibacterium salmoninarum strains. Dis. Aquat. Organ. 43:199-209.[Medline]
  48. 25
  49. O'Farrell, C. L., and M. S. Strom. 1999. Differential expression of the virulence-associated protein p57 and characterization of its duplicated gene msa in virulent and attenuated strains of Renibacterium salmoninarum. Dis. Aquat. Organ. 38:115-123.[Medline]
  50. 26
  51. Orihuela, C. J., J. N. Radin, J. E. Sublett, G. Gao, D. Kaushal, and E. I. Tuomanen. 2004. Microarray analysis of pneumococcal gene expression during invasive disease. Infect. Immun. 72:5582-5596.[Abstract/Free Full Text]
  52. 27
  53. Ortega, C., J. L. Muzquiz, J. Docando, E. Planas, J. L. Alonso, and M. C. Simon. 1995. Ecopathology in aquaculture: risk factors in infectious disease outbreak. Vet. Res. 26:57-62.[Medline]
  54. 28
  55. Pascho, R. J., D. G. Elliott, and S. Achord. 1993. Monitoring of the in-river migration of smolts from two groups of spring chinook salmon, Oncorhynchus tshawytscha (Walbaum), with different profiles of Renibacterium salmoninarum infection. Aquacult. Fish Manage. 24:163-169.
  56. 29
  57. Pascho, R. J., D. G. Elliott, and D. M. Chase. 2002. Comparison of traditional and molecular methods for detection of Renibacterium salmoninarum, p. 157-209. In C. O. Cunningham (ed.), Molecular diagnosis of salmonid diseases. Kluwer Academic Publishers, Dordrecht, The Netherlands.
  58. 30
  59. Pascho, R. J., D. G. Elliott, and J. M. Streufert. 1991. Brood stock segregation of spring chinook salmon Oncorhynchus tshawytscha by use of the enzyme-linked immunosorbent assay (ELISA) and the fluorescent antibody technique (FAT) affects the prevalence and levels of Renibacterium salmoninarum infection in progeny. Dis. Aquat. Organ. 12:25-40.
  60. 31
  61. Pascho, R. J., T. D. Goodrich, and C. L. McKibben. 1997. Evaluation by enzyme-linked immunosorbent assay (ELISA) of Renibacterium salmoninarum bacterins affected by persistence of bacterial antigens. J. Aquat. Anim. Health 9:99-107.
  62. 32
  63. Rhodes, L. D., A. M. Coady, and R. K. Deinhard. 2004. Identification of a third msa gene in Renibacterium salmoninarum and the associated virulence phenotype. Appl. Environ. Microbiol. 70:6488-6494.[Abstract/Free Full Text]
  64. 33
  65. Rhodes, L. D., A. M. Coady, and M. S. Strom. 2002. Expression of duplicate msa genes in the salmonid pathogen Renibacterium salmoninarum. Appl. Environ. Microbiol. 68:5480-5487.[Abstract/Free Full Text]
  66. 34
  67. Rockey, D. D., P. S. Turaga, G. D. Wiens, B. A. Cook, and S. L. Kaattari. 1991. Serine proteinase of Renibacterium salmoninarum digests a major autologous extracellular and cell-surface protein. Can. J. Microbiol. 37:758-763.[Medline]
  68. 35
  69. Sakai, M., S. Atsuta, and M. Kobayashi. 1992. Detection of Renibacterium salmoninarum antigen in migrating adult chum salmon (Oncorhynchus keta) in Japan. J. Wildl. Dis. 28:110-112.[Abstract]
  70. 36
  71. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  72. 37
  73. Sanders, J. E., J. J. Long, C. K. Arakawa, J. L. Bartholomew, and J. S. Rohovec. 1992. Prevalence of Renibacterium salmoninarum among downstream-migrating salmonids in the Columbia River. J. Aquat. Anim. Health 4:72-75.
  74. 38
  75. Senson, P. R., and R. M. W. Stevenson. 1999. Production of the 57 kDa major surface antigen by a non-agglutinating strain of the fish pathogen Renibacterium salmoninarum. Dis. Aquat. Organ. 38:23-31.[Medline]
  76. 39
  77. Starliper, C. E., W. B. Schill, and J. Mathias. 1998. Performance of serum-free broth media for growth of Renibacterium salmoninarum. Dis. Aquat. Organ. 34:21-26.[Medline]
  78. 40
  79. Teska, J. D. 1994. In vitro growth of the bacterial kidney disease organism Renibacterium salmoninarum on a nonserum, noncharcoal-based "homospecies-metabolite" medium. J. Wildl. Dis. 30:383-388.[Abstract]
  80. 41
  81. Turaga, P., G. Wiens, and S. Kaattari. 1987. Bacterial kidney disease: the potential role of soluble protein antigen(s). J. Fish Biol. 31:191-194.[CrossRef]
  82. 42
  83. VanderKooi, S. P., and A. G. Maule. 1999. Prevalence of Renibacterium salmoninarum in juvenile spring Chinook salmon at Columbia and Snake river hatcheries, 1993-1996. J. Aquat. Anim. Health 11:162-169.[CrossRef]
  84. 43
  85. Wiens, G. D., M. S. Chien, J. R. Winton, and S. L. Kaattari. 1999. Antigenic and functional characterization of p57 produced by Renibacterium salmoninarum. Dis. Aquat. Organ. 37:43-52.[Medline]
  86. 44
  87. Wiens, G. D., and S. L. Kaattari. 1991. Monoclonal antibody characterization of a leukoagglutinin produced by Renibacterium salmoninarum. Infect. Immun. 59:631-637.[Abstract/Free Full Text]
  88. 45
  89. Wood, P. A., and S. L. Kaattari. 1996. Enhanced immunogenicity of Renibacterium salmoninarum in chinook salmon after removal of the bacterial cell surface-associated 57 kDa protein. Dis. Aquat. Organ. 25:71-79.[CrossRef]
  90. 46
  91. Yoshimizu, M. 1996. Disease problems of salmonid fish in Japan caused by international trade. Rev. Sci. Tech. 15:533-549.[Medline]


Applied and Environmental Microbiology, April 2006, p. 2672-2678, Vol. 72, No. 4
0099-2240/06/$08.00+0     doi:10.1128/AEM.72.4.2672-2678.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Wiens, G. D., Rockey, D. D., Wu, Z., Chang, J., Levy, R., Crane, S., Chen, D. S., Capri, G. R., Burnett, J. R., Sudheesh, P. S., Schipma, M. J., Burd, H., Bhattacharyya, A., Rhodes, L. D., Kaul, R., Strom, M. S. (2008). Genome Sequence of the Fish Pathogen Renibacterium salmoninarum Suggests Reductive Evolution away from an Environmental Arthrobacter Ancestor. J. Bacteriol. 190: 6970-6982 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.
Agricola
Right arrow Articles by Coady, A. M.
Right arrow Articles by Rhodes, L. D.